NovaBay Pharma (NBY) Misses Q4 EPS by 15c
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Income (loss) before income taxes: -3.74M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Financial Fact:
Income (loss) before income taxes: -3.74M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Join SI Premium – FREE
NovaBay Pharma (NYSE: NBY) reported Q4 EPS of ($1.37), $0.15 worse than the analyst estimate of ($1.22). Revenue for the quarter came in at $2.4 million versus the consensus estimate of $3.15 million.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intel (INTC) PT Lowered to $92 at Mizuho
- Oxford Industries (OXM) Tops Q2 EPS by 4c; offers guidance
- John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
